Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Karius

Karius
2014 FOUNDED
PRIVATE STATUS
Debt LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
10 INVESTORS
Description

Provider of high-complexity clinical laboratory testing intended for generating genomic insights for infectious diseases. The company platform map each patient's microbial landscape from a single blood draw and develops molecular biology and data analysis tool that uses deep sequencing to detect minuscule traces of microbial DNA directly from blood, enabling clinicians, molecular biologists, data scientists, software engineers, and commercial experts to make rapid and life-saving treatment decisions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 975 Island Drive
  • Suite 101
  • Redwood City, CA 94065
  • United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Karius’s full profile, request a free trial.

Karius Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - General 30-Nov-2018 $25M 000.00 Completed Startup
3. Early Stage VC (Series A) 07-Aug-2017 0000 000.00 Completed Startup
2. Accelerator/Incubator $5.27M Completed Startup
1. Seed Round 20-Oct-2014 $5.27M $5.27M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Karius Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view this company’s complete Cap Table, request access »

Karius Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IDbyDNA Venture Capital-Backed San Francisco, CA 00 000 00000 00000 000
000000 0000000000 Venture Capital-Backed Saint Louis, MO 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
0000000 000000 Formerly VC-backed Redwood City, CA 000 00000 000000&0 00000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
To view this company’s complete list of competitors, request access »

Karius Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
aMoon Fund Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
Pacific 8 Ventures Venture Capital Minority 000 0000 000000 0
Tencent Holdings Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Karius Executive Team (5)

Name Title Board
Seat
Contact
Info
Mickey Kertesz Ph.D Co-Founder, Chief Executive Officer & Board Member
Sivan Bercovici Ph.D Chief Technology Officer
Tim Blauwkamp Ph.D Co-Founder, Chief Scientific Officer & Board Member

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »

Karius Board Members (5)

Name Representing Role Since Contact
Info
Mickey Kertesz Ph.D Karius Co-Founder, Chief Executive Officer & Board Member 000 0000
Scott Barclay Data Collective Board Member 000 0000
Tim Blauwkamp Ph.D Karius Co-Founder, Chief Scientific Officer & Board Member 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »